Yes, at one time over a period of a few months I just traded stocks that completed a reverse split. Usually a lot of shorts jumping in. Hopefully here with combo almost done, there is some people/organizations on the sidelines that has been waiting for this to get to $5 so they can invest. A lot companies do a cash raise right after the split usually at a discount to the share price, which puts downward pressure on the stock, which creates a perfect storm for shorting. For example if they R/S this down to 30M shares and then do a 30M share cash raise, they have essentially diluted the stock in 1 cash raise what took 10 years to dilute before. But I will say the price here has really held up nicely all these years. I've seen other biotech be in a cash crunch and do cash raises a quarter of the share price, management here has avoided that. I expect they will continue that trend post split.
News 
Market Data 
Discover 
